Skip directly to content

tagline 2007 September

tagline 2007

  • Rapidly Progressing Hepatitis C in New York Gay Men
    Recent outbreaks of acute hepatitis C virus (HCV) among HIV-positive men who have sex with men (MSM) have been reported in England, France, Germany, Holland, and the United States. Many of these cases were sexually transmitted, which is unusual because HCV is typically transmitted via injection drug use. Furthermore, many of these men were HIV-positive before they acquired HCV. Now, researchers in New York report a worrisome new finding: significant liver damage in HIV-positive MSM within months of HCV infection.
     
  • The Sitges Statement on HCV Drug Development
    In March 2007, a group of community activists, many living with HIV and hepatitis C virus (HCV), gathered with researchers, doctors, regulators, and representatives from Abbott, Roche, Schering, and Tibotec, in Sitges, Spain, at a meeting held by the European AIDS Treatment Group (EATG). The Sitges Statement was created at the end of the meeting, when all participants were asked to state their primary concerns about HCV drug development, trial designs, and access for coinfected people.
     
  • Studying New Drugs for HCV: Excerpts From the FDA Hearings
    The US Food and Drug Administration (FDA) convened a two-day meeting of its antiviral advisory committee in October 2006 to discuss drug development issues for new HCV agents. The panel was composed of clinicians, researchers, industry representatives, and community advocates.
     
  • Worldwide Antiretroviral Drug Sales 2006
    Chart provided by AIDSMeds.com based on SEC filings.
     
  • Faster TB Test for Resource-Limited Settings
    A large multicenter study conducted in Honduras and Brazil has shown that a new and relatively simple technique to detect active tuberculosis (TB), the microscopic observation drug susceptibility (MODS) test, is just as sensitive but about three times faster than conventional solid culture, the gold standard for confirming a diagnosis of active TB.
     
  • Basic Research is a Government Responsibility
    Excerpts from testimony by Robert Siliciano, M.D., Ph.D.before the US Senate Committee on Appropriations, March 19, 2007.
     
  • Immune Activation in HIV Infection: More Than Just Markers
    The role of immune activation in HIV infection has generally received less attention than HIV-associated immune deficiency. But recently, immune activation has received renewed attention for a number of important reasons.